NIH boosts translational funding

The National Institutes of Health linkurl:announced;http://www.nih.gov/news/health/may2008/ncrr-29.htm plans today (May 29) to inject $533 million over the next five years into speeding up the linkurl:bench to bedside;http://www.the-scientist.com/2008/3/1/29/1/ trajectory for new treatments. The funding will go to researchers at 14 academic health centers - including Harvard University, The Scripps Research Institute, Stanford University and others - which will become part of the NIH's Clinical

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
The National Institutes of Health linkurl:announced;http://www.nih.gov/news/health/may2008/ncrr-29.htm plans today (May 29) to inject $533 million over the next five years into speeding up the linkurl:bench to bedside;http://www.the-scientist.com/2008/3/1/29/1/ trajectory for new treatments. The funding will go to researchers at 14 academic health centers - including Harvard University, The Scripps Research Institute, Stanford University and others - which will become part of the NIH's Clinical and Translational Science Award (CTSA) consortium. "With more than half of NIH's funding allocated for basic research, the CTSA consortium is perfectly poised to help move discoveries in the laboratory to improved patient care," said NIH director Elias Zerhouni in an agency press release. "Through the consortium, we are better able to leverage expertise and resources across the CTSA institutions, and ultimately maximize NIH's investment in basic research, which should remain a top priority." The 2008 CSTA grants will fund genetics and genomics research projects, studies on pediatric diseases, and infection risk research, among other work. You can peruse the full list of 2008 CSTA awardees linkurl:here.;http://www.ncrr.nih.gov/clinical_research_resources/clinical_and_translational_science_awards/consortium_directory/
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo